Principles for designing future regimens for multidrug-resistant tuberculosis

Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes. One of the biggest barriers to scale-up is the treatment regimen, which is lengthy, complex, ineffective, poorly tolerated and expensive. For t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brigden, Grania, Nyang’wa, Bern-Thomas, du Cros, Philipp, Varaine, Francis, Hughes, Jennifer, Rich, Michael, Horsburgh, C Robert, Mitnick, Carole D, Nuermberger, Eric, McIlleron, Helen, Phillips, Patrick PJ, Balasegaram, Manica
Formato: Artigo
Idioma:Inglês
Publicado em: World Health Organization 2014
Assuntos:
Policy & Practice
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865549/
https://ncbi.nlm.nih.gov/pubmed/24391302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.13.122028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados